Atorvastatin for protease inhibitor-related hyperlipidaemia

被引：38

|

作者：

Murillas, J ^{[1
]}

Martín, T ^{[1
]}

Ramos, A ^{[1
]}

Portero, JL ^{[1
]}

机构：

[1] Hosp Clin Puerta Hierro, Madrid, Spain

来源：

AIDS | 1999年 / 13卷 / 11期

关键词：

D O I：

10.1097/00002030-199907300-00030

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：1424 / 1425

页数：2

相关论文

共 50 条

[21] Immune checkpoint inhibitor-related endocrinopathies
Lu, Difei
Gao, Ying
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2022, 10 (01) : 9 - 14
[22] Multikinase inhibitor-related psychiatric AEs
Reactions Weekly, 2023, 1967 (1) : 8 - 8
[23] Acetylcholinesterase inhibitor-related psychiatric AEs
Reactions Weekly, 2023, 1975 (1) : 9 - 9
[24] JAK inhibitor-related neurological AEs
Reactions Weekly, 2025, 2051 (1) : 9 - 9
[25] Immune checkpoint inhibitor-related thromboembolism
Reactions Weekly, 2022, 1922 (1) : 10 - 10
[26] ACE inhibitor-related uraemia preventable
Reactions Weekly, 1999, 736 (1) : 5 - 5
[27] ApoE genotype may affect protease inhibitor-associated hyperlipidaemia
Reactions Weekly, 1999, 759 (1) : 2 - 2
[28] ACE inhibitor-related hypoglycemia: Is it a real phenomenon?
Nieva, A
Asuncion, M
Norris, K
JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 56A - 56A
[29] DPP-4 inhibitor-related pemphigoid
Reactions Weekly, 2024, 1997 (1) : 3 - 3
[30] Immune checkpoint inhibitor-related autoimmune diseases
Reactions Weekly, 2021, 1861 (1) : 10 - 10

← 1 2 3 4 5 →